Core Insights - Willis Towers Watson (WTW) is a leading global advisory, broking, and solutions company valued at $30.7 billion, operating through Risk & Broking and Health, Wealth & Career segments [1] Company Performance - WTW stock has dropped 9.2% from its all-time high of $352.79 on October 7, and has declined 3.6% over the past three months, underperforming the S&P 500 Index which increased by 5.4% during the same period [3] - Year-to-date, WTW stock has gained 2.3% but has dipped 68 basis points over the past 52 weeks, while the S&P 500 has surged by 16.4% in 2025 and 12.4% over the past year [4] - Following the release of Q3 results on October 30, WTW's organic revenues grew by 5%, but overall topline remained flat at $2.3 billion due to the sale of TRANZACT, exceeding expectations by 53 basis points [5] Earnings and Margins - WTW reported a 10.8% year-over-year growth in adjusted EPS to $3.07, beating consensus estimates by 2.3% [5] - The company has shown solid improvement in margins despite the flat topline performance [5] Market Position - WTW has outperformed its peer Arthur J. Gallagher & Co., which experienced a 16.2% decline year-to-date and a 19.8% plunge over the past 52 weeks [6] - Among 23 analysts covering WTW stock, the consensus rating is a "Moderate Buy," with a mean price target of $366.68 indicating a 14.5% upside potential from current price levels [6]